Solid Biosciences (SLDB) Leases (2019 - 2026)
Quarterly results put Leases at $21.3 million for Q1 2026, down 10.2% from a year ago — trailing twelve months through Mar 2026 was $21.3 million (down 10.2% YoY), and the annual figure for FY2025 was $21.9 million, down 9.76%.
Solid Biosciences has reported Leases over the past 8 years, most recently at $21.3 million for Q1 2026.
- Leases reached $21.3 million in Q1 2026 per SLDB's latest filing, down from $21.9 million in the prior quarter.
- Across five years, Leases topped out at $28.9 million in Q4 2022 and bottomed at $722000.0 in Q1 2022.
- Median Leases over the past 5 years was $25.5 million (2024), compared with a mean of $24.1 million.
- The largest annual shift saw Leases crashed 77.41% in 2022 before it surged 3820.5% in 2023.
- Over 5 years, Leases stood at $28.9 million in 2022, then decreased by 8.32% to $26.5 million in 2023, then decreased by 8.46% to $24.3 million in 2024, then decreased by 9.76% to $21.9 million in 2025, then fell by 2.85% to $21.3 million in 2026.
- Business Quant data shows Leases for SLDB at $21.3 million in Q1 2026, $21.9 million in Q4 2025, and $22.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 21.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.30 Mn |
| Dec 31, 2025 | 21.92 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Jun 30, 2025 | 23.13 Mn |
| Mar 31, 2025 | 23.72 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Sep 30, 2024 | 24.86 Mn |
| Jun 30, 2024 | 25.51 Mn |
| Mar 31, 2024 | 26.10 Mn |
| Dec 31, 2023 | 26.54 Mn |
| Sep 30, 2023 | 27.19 Mn |
| Jun 30, 2023 | 27.84 Mn |
| Mar 31, 2023 | 28.31 Mn |
| Dec 31, 2022 | 28.95 Mn |
| Sep 30, 2022 | 28.44 Mn |
| Jun 30, 2022 | 28.94 Mn |
| Mar 31, 2022 | 722,000.00 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.23 Mn |
| Mar 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 3.58 Mn |
| Sep 30, 2020 | 3.95 Mn |
| Jun 30, 2020 | 4.31 Mn |
| Mar 31, 2020 | 4.66 Mn |
| Dec 31, 2019 | 4.99 Mn |
| Sep 30, 2019 | 5.53 Mn |
| Jun 30, 2019 | 5.62 Mn |
| Mar 31, 2019 | 5.92 Mn |